June 2011 Briefing - Ophthalmology
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for June 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
New Tool Validated for Vision-Related Quality of Life
TUESDAY, June 28 (HealthDay News) -- The Effects of Youngsters' Eyesight on Quality of Life (EYE-Q) instrument is a validated and reliable tool which may be useful for determining vision-related quality of life (VRQOL) in visually impaired children with juvenile idiopathic arthritis-associated uveitis (JIA-U), according to a study published online June 15 in Arthritis Care & Research.
Three-Year Retinal Screening Intervals Recommended
MONDAY, June 20 (HealthDay News) -- Retinal screening every three years can be recommended in patients with mild type 2 diabetes and no retinopathy, according to a study published in the June issue of Diabetes Care.
Unequal Care Access for Children With Public Insurance
THURSDAY, June 16 (HealthDay News) -- Access to outpatient care is restricted for children with public insurance compared to those with private insurance, according to a study published in the June 16 issue of the New England Journal of Medicine.
Increased Spending Seen for Glaucoma Medications in U.S.
WEDNESDAY, June 15 (HealthDay News) -- Expenditures on glaucoma medications increased significantly in the United States from 2001 to 2006, especially among women, those with public-only insurance, and those with less than a high school education, according to a study published online June 13 in the Archives of Ophthalmology.
Life Expectancy in U.S. Counties Below Many Nations
WEDNESDAY, June 15 (HealthDay News) -- Most counties within the United States fall behind the international frontier with the best life expectancies in the world, according to a study published online June 15 in Population Health Metrics.
Similar Number for Outpatient, Inpatient Malpractice Claims
TUESDAY, June 14 (HealthDay News) -- The number of paid malpractice claims is similar in both inpatient and outpatient settings, according to a study published in the June 15 issue of the Journal of the American Medical Association.
Ranibizumab May Reduce Impaired Vision in AMD
TUESDAY, June 14 (HealthDay News) -- Treatment of neovascular age-related macular degeneration (AMD) with ranibizumab may reduce legal blindness and visual impairment, according to a study published in the June issue of the Archives of Ophthalmology.
CDC: Ocular Toxocariasis Often Causes Permanent Vision Loss
THURSDAY, June 9 (HealthDay News) -- Ocular toxocariasis (OT) continues to occur in the United States, and it frequently leads to permanent vision loss that primarily affects children, according a report in the June 10 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Youth Bear Large Burden of Global Death, Disease
TUESDAY, June 7 (HealthDay News) -- Youths between the ages of 10 and 24 years carry 15.5 percent of the global burden of disability-adjusted life-years (DALYs), according to a study published online June 7 in The Lancet.
Precision Tinted Lenses May Help Reduce Migraine
THURSDAY, June 2 (HealthDay News) -- Use of precision ophthalmic tints (POTs) may reduce perceptual distortions and visual discomfort in migraine, possibly via a neurological pathway, according to a study published online May 26 in Cephalalgia.